Back to search
FDAFDA · Food and drugs·Recall number D-0174-2016

PAPA/PGE1/PHENTO (30mg/10mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

Published November 18, 2015 · Recall initiated: October 7, 2015

Summary

FDA records drug Class II recall D-0174-2016, published November 18, 2015 and initiated October 7, 2015. Recalling firm: Pacific Healthcare, Inc dba B&B Pharmacy; Status: Terminated; Reported quantity: 1-5 ml vial; 3-10 ml vials; Lot: 5 ml --- 07062015@2, exp 1/2/2016 10 ml --- 06042015@4, exp 12/1/2015; 06052015@15, exp 12/2/2015; 07132015@3, exp 1/9/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pacific Healthcare, Inc dba B&B Pharmacy
Distributor
CA and NJ
Lot
5 ml --- 07062015@2, exp 1/2/2016 10 ml --- 06042015@4, exp 12/1/2015; 06052015@15, exp 12/2/2015; 07132015@3, exp 1/9/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PAPA/PGE1/PHENTO (30mg/10mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA recalled?

Yes. FDA published recall D-0174-2016 on November 18, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter